β-catenin-IN-2

CAS No. 1458664-10-2

β-catenin-IN-2( —— )

Catalog No. M28838 CAS No. 1458664-10-2

β-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 264 In Stock
5MG 227 In Stock
10MG 359 In Stock
25MG 607 In Stock
50MG 849 In Stock
100MG 1144 In Stock
200MG Get Quote In Stock
500MG 2316 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    β-catenin-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    β-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.
  • Description
    β-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.(In Vitro):In HCT116 cells, β-catenin-IN-2 (10-40 μM) dose-dependently suppressed the transcriptional activity of the β-catenin/Tcf-4 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    H4 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1458664-10-2
  • Formula Weight
    255.29
  • Molecular Formula
    C15H14FN3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (326.41 mM)
  • SMILES
    CN(C)c(cc1)ccc1-c1nc(ccc(F)c2)c2[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sanna MD, et al. Histamine H4 receptor stimulation in the locus coeruleus attenuates neuropathic pain by promoting the coeruleospinal noradrenergic inhibitory pathway. Eur J Pharmacol. 2020 Feb 5;868:172859.
molnova catalog
related products
  • Wnt pathway activato...

    Wnt pathway activator 1 is a potent Wnt activator with an IC50 of 28-29 nM. Wnt pathway activator 1 is a potent Wnt activator for the treatment of androgenetic alopecia (AGA) extracted from patent WO2012024404A1.

  • Roquinimex

    Roquinimex (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.

  • Delafloxacin

    Delafloxacin (RX-3341, ABT-492) is a fluoroquinolone antibiotic agent. It has potent inhibitory against levofloxacin-resistant Streptococcus pneumoniae strains (MIC: 0.0078-0.125 μg/ml).